- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 30th, 2005
Eight months after raising hopes with their cutting edge ‘Golden Triangle’ technology for fighting cancer sans chemotherapy, nanoscientists at the National Chemical Laboratory (NCL) are gearing up for the technology’s first in-vitro tests.
The trials are being conducted to establish the toxicity of the gold nano-particles. "While gold is inherently non-toxic, we have to see exactly where the nano-sized triangles go when introduced into the cancerous area. We have kept a two-year window to see if we can get into clinical trials on humans."
|Related News Press|
New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015
Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
Two UCSB Professors Receive Early Career Research Awards: The Department of Energy’s award for young scientists acknowledges UC Santa Barbara’s standing as a top tier research institution May 29th, 2015